#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive supranuclear palsy Hidradenitis Pleomorphic liposarcoma Hairy cell leukaemia Carcinoid tumour Liver abscess Arginase deficiency Small cell lung cancer IgA nephropathy Angiosarcoma non-metastatic Henoch-Schonlein purpura Adenomatous polyposis coli Dementia with Lewy bodies Nephroblastoma Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Basic Information Metachromatic leukodystrophy – Life with Disease Niemann-Pick disease – Treatment Congenital generalised lipodystrophy Retinoblastoma – Basic Information Haemophilia A with anti factor VIII – Basic Information Mastocytosis – Trials in Disease Advanced systemic mastocytosis – Treatment SAPHO syndrome – Life with Disease Hairy cell leukaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BENZYLPENICILLIN POTASSIUM Gsk3915393 Pegargiminase Doxycycline Monohydrate Enzalutamide Foscarnet Sodium Hexahydrate Lamivudine Zofenopril Calcium Valbenazine Ditosylate Fosinopril Sodium Alkaline Phosphatase, Bovine SODIUM BENZOATE Epcoritamab BLEXIMENIB Gsk3858279 Calcitriol Epoetin Alfa LTG-001 Pilocarpine Hydrochloride Interferon Gamma More therapies…

    Learn about Your Condition

    Albright's disease Orthostatic hypotension Acute myeloid leukaemia Ewing's sarcoma Head and neck cancer stage III Noonan syndrome Endotracheal intubation Retinal neovascularisation Castleman's disease Colorectal cancer stage IV Seizure Intestinal obstruction Endometrial cancer recurrent Atrial fibrillation Neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effectiveness of nicotinamide in patients with Leber’s hereditary optic neuropathy who have experienced vision loss within the last 18 months

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hereditary optic atrophy
    Investigated Drugs:
    • Nicotinamide
    France

  • Study of the effect of metyrapone in patients with mild Cushing syndrome caused by primary bilateral macronodular adrenal hyperplasia

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Metyrapone
    France

  • A study to evaluate the effect of xanomeline tartrate and trospium chloride on cognitive impairment in adults with schizophrenia.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Austria Belgium Czechia Denmark Germany Hungary +3

  • A study to evaluate the use of botulinum toxin type A – haemagglutinin complex to help close the abdomen in patients with an open abdomen.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Spain

  • A study to evaluate the safety and effectiveness of VTX2735 sodium in patients with recurrent pericarditis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VTX2735 SODIUM
    Belgium France Greece

  • A study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Spain
Previous Page
1 … 737 738 739 740 741 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!